Gastroent Hepat Barc
-
Gastroent Hepat Barc · May 1999
Review Case Reports[Severe hepatitis from therapeutic doses of paracetamol in an alcoholic patient].
The case of a 36-year-old chronic alcoholic patient who came to the hospital for presenting general bad shape, arthromyalgia and jaundice and who developed severe hepatitis with an extreme elevation in the transaminase levels following the consumption of therapeutic doses of paracetamol (3 g/day for 4 days). The possibility of other causes of hepatitis were duly discarded. ⋯ Recognizing hepatotoxicity by paracetamol in alcoholics is simple if the clinical history, the marked transaminase elevation and the history of paracetamol intake are adequately evaluated. Lower doses of paracetamol or even avoidance of this drug is recommended in circumstances in which the toxicity of the drug may be potentiated by chronic alcohol consumption or by the lack of appetite associated with deficient alimentation.
-
Gastroent Hepat Barc · May 1999
Review Case Reports[Pyoderma gangrenosum with an atypical location and a rapid response to cyclosporin A].
Pyoderma gangrenosum is an unusual neutrophilic dermatosis associated to different rheumatologic, haematologic and inflammatory bowel diseases which generally responds to the therapy of the underlying disease. We report a case of pyoderma in a 44-years-old woman with paucisymptomatic, distal, ulcerative colitis which appeared simultaneously in her forehead and hands. We think it of general interest because of its localization, its importance, the failure of response to steroids and the need of cyclosporine A for regression.
-
Gastroent Hepat Barc · May 1999
Comparative Study[The predictive factors of a good response to the transfusion of erythrocyte concentrates in patients with controlled digestive hemorrhage].
Not all patients respond the same to the transfusion of erythrocyte concentrates (EC) after achieving the control of gastrointestinal bleeding. ⋯ 1. The hemodynamic state and the degree of basal anemia do not condition response to EC transfusion in controlled gastrointestinal bleeding. 2. The response to the administration of EC is better in women and subjects of lower body surface. 3. Postransfusional analytical control at 4 hours allows early evaluation of the effects of the transfusion in patients at risk of recurrent hemorrhage.